http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-639935-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 |
| filingDate | 1978-12-05^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ee293bac6fb50ec22baf58a7ef9aa5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee7248c42590a06c5dcc037f5be4b50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b037891f30c29cb1e4caa5ebb25bf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87bb64bb81e793bfeb672c76f952ce35 |
| publicationDate | 1983-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CH-639935-A5 |
| titleOfInvention | 16-Substituted 16-hydroxyprostanoic, 5-prostenoic and -prostadienoic acid esters and processes for their preparation |
| abstract | 16-Substituted 16-hydroxyprostanoic, 5-prostenoic and -prostadienoic acid esters correspond to the formula: <IMAGE> Racemic mixtures of compounds of this formula and mirror images thereof are also possible. R1 denotes a methyl or ethyl radical, R2 an alkyl radical having 2 to 7 carbon atoms, and T denotes one of the following divalent radicals: <IMAGE> in which R5 denotes a vinyl or cyclopropyl group, Z denotes -(CH2)6- or <IMAGE> and C13-C14 denotes ethylene or trans-vinylene. These compounds are used therapeutically, inter alia as hypotensives, oxytocics, for the prophylaxis and treatment of thrombosis and of gastric ulcer, for example intravenously, intramuscularly, subcutaneously, orally, intravaginally, rectally, sublingually, topically and in the form of sterile implants with a prolonged duration of action. |
| priorityDate | 1978-12-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 273 of 273.